Willard H. Dere - Oct 2, 2023 Form 4 Insider Report for Mersana Therapeutics, Inc. (MRSN)

Role
Director
Signature
/s/ Alejandra Carvajal, Attorney-in-Fact
Stock symbol
MRSN
Transactions as of
Oct 2, 2023
Transactions value $
$0
Form type
4
Date filed
10/4/2023, 04:30 PM
Previous filing
Jul 6, 2023
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRSN Common Stock Award $0 +11K +49.92% $0.00 33.1K Oct 2, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were granted in connection with the Reporting Person's election to receive the Reporting Person's quarterly retainer for director services in the form of fully vested shares of stock rather than cash. The shares were granted to the Reporting Person pursuant to the Issuer's Amended & Restated Non-Employee Director Compensation Policy in lieu of retainer fees of $13,875 for the quarter ended September 30, 2023. The number of shares issued was based on the closing price per share of the Issuer's common stock on October 2, 2023, which was $1.26.